Beta defensins as biomarkers: detectable in LPS-stimulated equine peripheral blood mononuclear cells and normal, aseptic, and probable septic equine synovial fluid.

The research article focuses on the role of beta defensins (a type of protein) in diagnosing equine septic arthritis. The study investigates their presence in horse synovial fluid and their potential as a useful biomarker of sepsis in horses.

Objective of the Research

• The research aims to identify the presence and activity of beta defensins in equine synovial fluid, and their potential utility as a biomarker for septic arthritis in horses.
• It compares the in vitro gene expression of lipopolysaccharide (LPS)-stimulated equine neutrophils to unstimulated neutrophils and evaluates BD protein expressions in different equine joint conditions, such as normal, aseptically inflamed, and septic.

Methods

• The research method involved testing 5 horses for beta defensin expression in isolated neutrophils and analyzing 21 synovial fluid samples from 14 horses.
• Further, the research used RT-qPCR analysis to examine the beta defensin gene expression in stimulated and unstimulated equine peripheral neutrophils.
• The researchers also evaluated beta defensin protein expression levels in equine synovial fluid from different joint conditions using an ELISA test and analyzed the outcomes with a Kruskal-Wallis test.

Results

• The researchers noted a significant increase in the expression of beta defensin-3 in LPS-stimulated equine neutrophils compared to unstimulated ones.
• However, the study did not find any significant differences in beta defensin expressions between equine joints experiencing normal conditions, aseptic inflammation, and septic inflammation.
• The limitations of the study included a low number of cases and variations in the types of cases within the aseptic inflammation group.

Conclusions

• The research concluded that beta defensins can be found in equine synovial fluid and can be stimulated from peripheral neutrophils.
• Though beta defensins were present, their exact role as biomarkers for equine joint disease needs further investigation.